- Recent Funding
- Investors
- ARCH Venture Partners
ARCH Venture Partners portfolio
ARCH Venture Partners has 29 portfolio companies on record at Recent Funding, with 5 investments in the last 12 months.
About this page
It is a venture capital firm based in Chicago, US, founded in 1989. It led 11 of the 31 rounds it joined. Its most recent investment on record is Oratomic's $475M Series B+ round in October 2026, which it led, alongside Khosla Ventures, General Catalyst, Bezos Expeditions and 2 others. By category, its portfolio leans toward Health and bio (26) and Robotics and hardware (4). It has co-invested with GV, Invus and OrbiMed, most often GV (8 rounds).
About ARCH Venture Partners
Fund returns
| Fund | Vintage | Size | Net IRR | TVPI | DPI | As of |
|---|---|---|---|---|---|---|
| ARCH VENTURE FUND XIII LP | 2023 | — | 39.8% | 1.25x | 0.00x | Dec 31, 2025 |
| Arch IX Overage | 2016 | — | 26.0% | 2.85x | 1.89x | Jun 30, 2024 |
| ARCH VENTURE FUND VI LP | 2003 | — | 2.4% | 1.24x | 1.24x | Jun 30, 2025 |
| ARCH VENTURE FUND IX LP | — | — | 24.2% | 2.58x | 1.53x | Jun 30, 2024 |
| ARCH VENTURE FUND VIII LP | — | — | 21.6% | 3.19x | 2.44x | Jun 30, 2024 |
What ARCH Venture Partners invests in
- Health and bio · 26 · 90%
- Robotics and hardware · 4 · 14%
- Data and analytics · 4 · 14%
- Manufacturing and industrial · 3 · 10%
- Logistics and mobility · 3 · 10%
- Education · 1 · 3%
- Consumer and social · 1 · 3%
- AI infrastructure and compute · 1 · 3%
ARCH Venture Partners recent investments
| Company | Round | Date | Alongside |
|---|---|---|---|
| Series B+ · $475M · lead | Khosla Ventures (lead), General Catalyst (lead), Bezos Expeditions (lead) +2 | ||
| Series B+ · $188M | Milky Way Investments (lead), Gates Frontier, GSK +2 | ||
| Series B+ · $75M | Milky Way Investments (lead), LoLa Capital Partners, Gates Frontier +5 | ||
| Series B+ · $275M | Khosla Ventures, Medtronic, General Atlantic (lead) +1 | ||
| Series B+ · $99.5M | Viking Global Investors (lead), Casdin Capital, Slate Path Capital +6 | ||
| Series B+ · $40M · lead | Moore Strategic Ventures, Sands Capital Ventures, Tao Capital +2 | ||
| Series A · $200M | AbbVie, Leaps by Bayer, Vida Ventures +4 | ||
| Series A · $200M | Casdin Capital, AI Life Sciences Investments LLC (lead), Fidelity +7 |
How ARCH Venture Partners invests
ARCH Venture Partners portfolio companies
OOratomic$475MSeries B+ · Oct 2026
LLifeMine Therapeutics$188MSeries B+ · Aug 2026
SSynchron$275MSeries B+ · Jun 2026
CCity Therapeutics$99.5MSeries B+ · Jun 2026
EElephas Biosciences$40MSeries B+ · Nov 2025
SSoufflé Therapeutics$200MSeries A · Oct 2025
TTreeline Biosciences$200MSeries A · Sep 2025
RRhyGaze$86MSeries A · Jan 2025
MMirador Therapeutics$400MSeries A · Mar 2024
AAreteia Therapeutics$75MSeries A · Feb 2024
AAccompany Health$56MSeries A · Jan 2024
HHI-Bio$95MSeries B+ · Jan 2024
MMagnet Biomedicine$50MSeries A · Sep 2023
OOrbital Therapeutics$270MSeries A · Apr 2023
PParatus Sciences$100MSeries A · Mar 2023
HHomeward Health$50MSeries B+ · Aug 2022
OONI$75MSeries B+ · Jan 2022
CCytrellis Biosystems$50MSeries B+ · Sep 2021
EEncodia$75MSeries B+ · Jan 2021
AAspen Neuroscience$70MSeries A · Apr 2020
AAtlas Data Storagebacker
AArbor Biotechnologiesbacker
TTenviebacker
LLightcastbacker
AAkamis Biobacker
LLifordi Immunotherapeuticsbacker
QQuantum Circuitsbacker
Bbit.biobacker
XXaira Therapeuticsbacker
| Company | Round with ARCH Venture Partners | Total raised | Latest raise |
|---|---|---|---|
Robotics and hardware |
Series B+ · $475M · lead | $775M | Oct 8, 2026 Series B+ |
Health and bio |
Series B+ · $188M | $543M | Aug 6, 2026 Series B+ |
Health and bio |
Series B+ · $275M | $600M | Jun 29, 2026 Series B+ |
Health and bio |
Series B+ · $99.5M | $234.5M | Aug 8, 2026 Series B+ |
Health and bio |
Series B+ · $40M · lead | $95M | Nov 6, 2025 Series B+ |
Health and bio |
Series A · $200M | $335M | Oct 13, 2026 Series B+ |
Health and bio |
Series A · $200M | $461M | Sep 3, 2025 Series A |
Health and bio |
Series A · $86M | $97M | Jan 10, 2025 Series A |
Health and bio |
Series A · $400M · lead | $650M | Jan 13, 2026 Series B+ |
Health and bio |
Series A · $75M | $75M | Feb 13, 2024 Series A |
Health and bio |
Series A · $56M | $56M | Jan 30, 2024 Series A |
Health and bio |
Series B+ · $95M | $215M | Jan 4, 2024 Series B+ |
Health and bio |
Series A · $50M · lead | $50M | Jul 13, 2026 Series A |
Health and bio |
Series A · $270M · lead | $270M | Aug 3, 2025 Series A |
Health and bio |
Series A · $100M · lead | $100M | Mar 8, 2023 Series A |
Health and bio |
Series B+ · $50M · lead | $50M | Aug 3, 2022 Series B+ |
Health and bio |
Series B+ · $75M · lead | $75M | Jan 29, 2022 Series B+ |
Health and bio |
Series B+ · $50M | $78.5M | Sep 21, 2021 Series B+ |
Health and bio |
Series B+ · $75M | $75M | Jun 26, 2024 Series A |
Health and bio |
Series A · $70M | $339M | Nov 20, 2025 Series B+ |
AI infrastructure and compute |
backer | $161M | Mar 5, 2026 Seed |
Health and bio |
backer | $289M | Mar 18, 2025 Series B+ |
Health and bio |
backer | undisclosed | Jan 8, 2025 round |
Health and bio |
backer | $27M | Apr 14, 2026 round |
Health and bio |
backer | $60M | Dec 17, 2024 Series A |
Health and bio |
backer | undisclosed | Nov 18, 2025 Series A |
Robotics and hardware |
backer | $78M | Aug 16, 2024 Series B+ |
Health and bio |
backer | $75M | Nov 4, 2026 Series B+ |
Health and bio |
backer | $1B | Mar 23, 2026 round |
Most frequent co-investors
GGV8 shared rounds · last Aug 6, 2026
IInvus5 shared rounds · last Aug 6, 2026
OOrbiMed5 shared rounds · last Sep 3, 2025
AAlexandria Venture Investments5 shared rounds · last Mar 21, 2024
CCasdin Capital4 shared rounds · last Jun 8, 2026
RRock Springs Capital4 shared rounds · last Jun 8, 2026
MMoore Strategic Ventures4 shared rounds · last Nov 6, 2025
KKhosla Ventures3 shared rounds · last Oct 8, 2026
BBezos Expeditions3 shared rounds · last Oct 8, 2026
MMilky Way Investments3 shared rounds · last Aug 6, 2026
VViking Global Investors3 shared rounds · last Jun 8, 2026
FFidelity3 shared rounds · last Jun 8, 2026
Similar investors
HHTGF29 companies · 8 deals in 12 mo
EEurazeo29 companies · 4 deals in 12 mo
MMubadala Capital Ventures31 companies · 5 deals in 12 mo
AAtomico27 companies · 8 deals in 12 mo
SS3227 companies · 6 deals in 12 mo
HHaystack32 companies · 6 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Net returns as reported by the public-pension and foundation LPs invested in each fund.
Firm profile and fund returns: Fundraising Fox Open Dataset v2026-11, CC BY 4.0. Track-record counts are theirs, not Recent Funding's.
Share is of the 31 rounds on Recent Funding that name ARCH Venture Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists ARCH Venture Partners, which is a subset of its real portfolio. API: /api/v1/investors/arch-venture-partners (get a free API key). More: the most active VC firms and new venture capital funds.
The week's top funded startups and market insights, in your inbox every Monday.
Unsubscribe anytime · privacy